Introduction
Systemic sclerosis (SSc)' is a connective tissue disease characterized by fibrosis of the skin, subcutaneous tissue, and various 1 . Abbreviations used in this paper: 11F, indirect immunofluorescence; NC, noncollagenous; RT-PCR, reverse transcription-PCR; SSc, systemic sclerosis.
internal organs (1) . The most prominent pathologic manifestation ofthe disease is an abnormal accumulation ofextracellular matrix components, predominantly collagen types I and III (2) (3) (4) . More recent data have also shown an increased expression of type VI collagen, mainly in a perivascular location (5) . In vitro, fibroblast cultures established from SSc patients' involved skin express increased amounts of collagens type I, III, and V, fibronectin, and proteoglycans (6-1 1), and contain elevated levels of a 1(I), a2(I), and a 1(111) collagen mRNAs (12) (13) (14) . Transient transfection assays have also shown increased activity ofthe a2(I) collagen promoter-reporter gene construct in SSc fibroblasts (15) , suggesting enhancement of type I collagen gene expression at the transcriptional level.
TGF-3 consists ofa family ofclosely related cytokines. Two members ofthe family, TGF-f31 and TGF-f32, have been implicated in the pathogenesis of a variety of fibrotic diseases ( 16, 17) , and several lines of evidence suggest that TGF-f3 plays a critical role in the development of tissue fibrosis in SSc. For example, TGF-f 1 has been shown to stimulate the synthesis of various connective tissue components by normal fibroblasts in vitro ( 1 8, 19) , and when injected intradermally TGF-f. causes tissue fibrosis (20) . Furthermore, an abundance of TGF-f in the skin of SSc patients (21, 22 ) and the responsiveness of SSc fibroblasts to stimulation by TGF-3 (23, 24) make this growth factor a potential candidate molecule in the pathogenesis of SSc. Type VII collagen consists of three identical a I(VII) chains, each composed of a long collagenous triple-helix flanked by globular amino-and carboxy-terminal noncollagenous domains (25) (26) (27) . Type VII collagen is present in human tissues in a restricted distribution, almost exclusively in the basement membrane zone below stratifying squamous epithelia of the skin, mucous membranes, and the cornea of the eye. Type VII collagen is the predominant, if not the exclusive, component of anchoring fibrils, attachment structures which ensure the integrity of the cutaneous basement membrane zone (for reviews see references 27, 28). Under in vitro conditions, type VII collagen is synthesized primarily by epidermal keratinocytes, but dermal fibroblasts have also been shown to express the type VII collagen gene at a very low level (29, 30) . The synthesis oftype VII collagen can be upregulated by TGF-,B1 and TGF-f2 both in keratinocyte and fibroblast cultures (30, 31) .
The aim of the present study was to assess the expression and distribution of type VII collagen and TGF-f in the skin of SSc patients and to examine the expression of the type VII collagen gene in SSc fibroblast cultures.
Methods
Patients. This study was performed on skin specimens from seven patients, six of them having a definitive diagnosis of diffuse SSc and one being suggestive of SSc (Raynaud's phenomenon and positive test for antinuclear antibody). Also, dermal fibroblast cultures were established from eight patients with diffuse SSc of recent onset. In one case, the skin specimens and cultured fibroblasts were obtained from the same patient. The diagnosis of SSc was made according to the criteria of the American College of Rheumatology (formerly American Rheumatism Association) (32), and none ofthe patients had a limited form of SSc. Clinical features and laboratory findings ofthe 15 patients (S1-S 15) are summarized in Table I . Control fibroblast cultures were established from eight age-and sex-matched healthy individuals, and normal skin specimens were obtained from three healthy individuals. Full thickness excisional skin biopsies were obtained from the leading edge of the fibrotic process on the dorsal forearm of SSc patients and from site-matched areas from healthy individuals. Each specimen was cut into two pieces. One part was immediately frozen in liquid nitrogen, and 5-Mim-thick frozen sections were used for indirect immunofluorescence (IIF). The second piece was used to establish fibroblast cultures. For IIF, cells were grown on chamber slides (Nunc, Inc., Naperville, IL) to subconfluency. All fibroblast cultures were maintained in DME supplemented with 10% FCS. In experiments testing the effects of TGF-3, the cells were rinsed with PBS and replaced in DME containing 1% FCS 3 h before addition of 10 ng/ml TGF-#31 MI) . Differences in the efficiency of PCR amplification were corrected for by using a cloned cDNA as internal standard which contained complementary sequences for the same primers and yielded the same size product but contained a single base substitution in the sequence GAGAAG instead of GAGATG found in the normal sequence (35). The mutated PCR product could be cleaved by the endonuclease Earl into 244-and 138-bp fragments (Fig. 1) . This homozygous T-to-A substitution has been detected in two siblings with recessive dystrophic epidermolysis bullosa (35). The product of PCR amplification was subcloned into the PCR 1000 vector (Invitrogen, San Diego, CA), amplified, and the plasmid construct was linearized with restriction enzyme digestion using EcoRI (Boehringer Mannheim Corp.). 100 pg of the cDNA containing the mutated sequence (T-to-A substitution) was used as an internal standard mixed with the cDNA template generated by RT-PCR from RNA isolated from fibroblast cultures established from SSc patients or from matched control individuals. 200 pg of cDNA containing the internal standard was used for experiments with cDNA from TGF-#-stimulated fibroblasts.
Each PCR reaction product was extracted with phenol-chloroform, digested to completion with the restriction enzyme Earl, and subsequently analyzed by electrophoresis on a 4% polyacrylamide gel (33) . The gel was exposed to x-ray film (X-Omat; Eastman Kodak, Rochester, NY) at -70°C for varying time periods, and the autoradiographic signals were quantitated by scanning densitometry in the linear range of the autoradiograms. The intensity of the 382-bp band was normalized by the signal from the 244-bp cleavage product derived from the internal standard. Control experiments indicated that cleavage of the PCR product containing the Earl site was complete (35).
IIF. The slides containing either skin sections or cultured cells were rinsed with PBS and fixed with ice-cold 100% ethanol. For detection of type VII collagen, after a 30-min incubation with 1% BSA in PBS, the samples were exposed to an anti-type VII collagen mAb (36) (L3D; provided by Dr. Robert Briggaman, University of North Carolina, Chapel Hill, NC) for 45 min at room temperature. Similar procedures were used for the detection ofTGF-, I or TGF-,#2 epitopes using mAbs (provided by Dr. David R. Olsen, Celtrix Laboratories, Santa Clara, CA). The slides were then rinsed with PBS and exposed to a rhodamine-conjugated monoclonal anti-mouse IgG antibody (Cappel Labo- (Fig. 3) . Demonstration ofelevated type VII collagen expression at the protein level by IIF. To evaluate the expression of type VII collagen at the protein level, IIF with an mAb recognizing an epitope in the amino-terminal noncollagenous (NC) domain (NC-1) (37) was performed on cultured SSc and control cells. As reported previously (29) , unstimulated dermal fibroblasts from healthy controls display a faint, yet clearly detectable, staining reaction (+) for type VII collagen epitopes (Fig. 4 A) . Fibroblasts from eight SSc patients were stained in parallel with the same monoclonal anti-type VII collagen antibody (36) . In five cases, an intense (++) to very intense (+++) staining reaction, as illustrated in Fig. 4 B, could be observed. In the remaining three cases, no apparent difference between the control and SSc fibroblasts could be noted (not shown). Exposure of control fibroblasts to either TGF-O 1 or TGF-32 resulted in a marked increase in the immunofluorescence, in accordance with previous results (30, 31 ) . The relative increase after stimulation with TGF-f seemed somewhat less pronounced in SSc fibroblasts, probably reflecting the higher baseline staining in unstimulated control cultures. However, the intensity of the immunofluorescence appeared to be equally strong in both control and SSc fibroblasts after stimulation with TGF-#.
IIF of skin sections from healthy controls showed an intense staining (+++ or ++++) for type VII collagen at the dermal-epidermal junction, and similar staining was observed at the basement membrane zone of the skin specimens from SSc patients (Fig. 5 ). In addition, six out of eight SSc patients Fig. 2 ) and matched control cultures were incubated without (-) or with (+) 1O ng/ml of TGF-,B for 24 h. Type VII collagen mRNA levels were determined by RT-PCR, as described in Methods and in Fig. 2, using an showed an intense (++ or +++) staining reaction throughout the dermis (Fig. 5, B and C, and Table II ). In two cases (S4 and S5), the staining reaction appeared to be more intense in the reticular dermis, as compared with the papillary dermis (Fig. 5  B) . In two patients (S2 and S3), the presence oftype VII collagen was also noted within the epidermis (Fig. 5 C) , and in one patient (S3) distinct staining reaction for type VII collagen was also detected in the subcutaneous tissue (Fig. 6 A) . Parallel staining ofcontrol skin specimens revealed essentially negative staining reaction (-or ±) in the epidermis and dermis (Fig. 5  A) and the subcutaneous adipose tissue (Fig. 6 B) .
Detection of TGF-,# epitopes in the affected skin ofSSc patients. Since TGF-,3 has previously been shown to upregulate type VII collagen gene expression both at the protein and mRNA levels (30, 3 1 ) , the presence of TGF-#3l and TGF-f2 epitopes was also evaluated in the skin specimens of the eight patients with SSc and compared with control skin samples from three healthy individuals. In healthy individuals, the presence of TGF-#3I and TGF-I2 epitopes could be observed in the epidermis (±, +, or ++), while the staining reaction in the dermis was essentially negative (Fig. 7, A and B) . In SSc patients, TGF-#3l and TGF-f32 epitopes were clearly detectable in the epidermis and dermis of all patients studied (Fig. 7, C and D, and Table II) . Staining for TGF-l3I and TGF-ff2 epitopes in subcutaneous tissue was also performed in one healthy control and three patients with SSc. In the healthy individual, staining for both forms of TGF-f3 was entirely negative (Fig. 6 D and  Table II ). In contrast, in two out of three patients with SSc, both TGF-f3I and TGF-,32 epitopes were detected (Fig. 6 Cand Table II ). In general, a correlation could be observed between the relative staining intensity of TGF-f and type VII collagen epitopes in the dermis of SSc patients (Table II) .
Electron microscopy. Ultrastructural analysis of the skin from two affected patients revealed a normal appearing epidermis with a continuous basement membrane and anchoring fibrils, and the subepidermal region, as expected, contained an increased amount of collagen arranged in thick interweaving bundles (not shown). Of particular interest was the observation that the deeper dermis contained numerous aggregates of filamentous structures which were interspersed between the collagen bundles and the elastic fibers. These filaments were 15-20 nm in thickness and up to 200 nm in length. In some instances, these filaments interacted end-to-end, formed elongated structures, and occasionally showed a curvilinear conformation similar to that observed in the anchoring fibrils associated with the basement membrane at the dermal-epidermal junction (28). These findings suggest that these filaments may represent abnormal type VII collagen aggregates, but their exact biochemical composition could not be determined.
Discussion
Type VII collagen is the major, if not the exclusive, constituent of anchoring fibrils (38) . These fibrils play an essential role in (27, 39, 40) , and an acquired autoimmune disease, epidermolysis bullosa acquisita (41 ) . To date, no example ofpathologic upregulation of type VII collagen in an ectopic topographic location has been described. However, a previous ultrastructural study has indicated the presence of anchoring fibrils in the lung tissue of patients with idiopathic pulmonary fibrosis; these fibrils were not detected in normal lungs (42) . Since the anchoring fibrils observed in the lung tissue resemble those found in normal skin, it is conceivable that type VII collagen levels may also be increased in the fibrotic lung tissue in SSc. stabilizing the association of the basement membrane to the underlying dermis and, consequently, provide integrity to the cutaneous basement membrane zone (28). In normal skin, the distribution of type VII collagen is essentially restricted to the dermal-epidermal basement membrane zone, the site of anchoring fibrils. Decreased expression of type VII collagen and/ or impaired assembly of this collagen into anchoring fibrils has been associated with blistering skin diseases, including the heri- ( 15, 43) . Also, there was a general correlation between the relative intensity of staining reaction of TGF-,B and type VII collagen epitopes within individual skin specimens. Collectively, these results suggest that the abundance of type VII collagen in SSc dermis may result from increased local expression of TGF-f3.
Clinically, induration and thickening of the skin which is tightly bound to the underlying tissue are the hallmark of SSc. The presence oftype VII collagen and fibrillar structures in the dermis may provide an explanation for this appearance of the affected skin in SSc patients, and this effect could be expected to be detectable only in the affected area of the skin. The accumulation of type VII collagen in the skin could result from upregulation of the corresponding gene by TGF-,B. In this context, it is of interest to note that TGF-f31 has been shown to increase its own expression in an autocrine manner, while TGF-32 increases the expression of TGF-#31 and TGF-f32 (44) .
Consequently, an early increase in the local expression ofTGFfi 1 or TGF-,B2 could perpetuate their expression, thus resulting in continued expression oftype VII collagen and other TGF-j3-responsive genes in chronic fibrotic conditions. Thus, attempts to counteract the effects of TGF-3 with other cytokines (45, 46) or to inhibit type VII collagen gene expression by novel approaches, such as the use of antisense oligomers (47) , might be helpful in preventing the progression or even in reversing some of the clinical manifestations of SSc.
